Drugs for COVID-19
December 11, 2023

A selective serotonin reuptake inhibitor (SSRI) is generally used for initial treatment of major depressive disorder (MDD). A serotonin-norepinephrine reuptake inhibitor (SNRI), bupropion (Wellbutrin SR, and others), and mirtazapine (Remeron, and others) are reasonable alternatives. Improvement in symptoms can occur within the first two weeks of treatment with these drugs, but a substantial benefit may not be achieved for 4-8 weeks.1


SSRIs — There is no convincing evidence that any one SSRI is more effective than any...  Continue reading

Coming Soon
Zuranolone (Zurzuvae) for Postpartum Depression
Vonoprazan (Voquezna) for Erosive Esophagitis
Tirzepatide (Zepbound) for Chronic Weight Management
Drugs for Acne and Rosacea